BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23831922)

  • 1. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
    Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E
    Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
    Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
    Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia.
    Lo Nigro L; Mirabile E; Tumino M; Caserta C; Cazzaniga G; Rizzari C; Silvestri D; Buldini B; Barisone E; Casale F; Luciani M; Locatelli F; Messina C; Micalizzi C; Pession A; Parasole R; Santoro N; Masera G; Basso G; Aricò M; Valsecchi M; Biondi A; Conter V;
    Leukemia; 2013 Dec; 27(12):2419-21. PubMed ID: 23670296
    [No Abstract]   [Full Text] [Related]  

  • 4. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
    Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.
    Dreyling MH; Schrader K; Fonatsch C; Schlegelberger B; Haase D; Schoch C; Ludwig W; Löffler H; Büchner T; Wörmann B; Hiddemann W; Bohlander SK
    Blood; 1998 Jun; 91(12):4662-7. PubMed ID: 9616163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.
    Mulaw MA; Krause A; Deshpande AJ; Krause LF; Rouhi A; La Starza R; Borkhardt A; Buske C; Mecucci C; Ludwig WD; Lottaz C; Bohlander SK
    Leukemia; 2012 May; 26(5):1012-9. PubMed ID: 22064352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.
    Asnafi V; Radford-Weiss I; Dastugue N; Bayle C; Leboeuf D; Charrin C; Garand R; Lafage-Pochitaloff M; Delabesse E; Buzyn A; Troussard X; Macintyre E
    Blood; 2003 Aug; 102(3):1000-6. PubMed ID: 12676784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides.
    Silliman CC; McGavran L; Wei Q; Miller LA; Li S; Hunger SP
    Leukemia; 1998 Sep; 12(9):1404-10. PubMed ID: 9737689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
    Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
    Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia.
    Carlson KM; Vignon C; Bohlander S; Martinez-Climent JA; Le Beau MM; Rowley JD
    Leukemia; 2000 Jan; 14(1):100-4. PubMed ID: 10637483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.
    Deshpande AJ; Rouhi A; Lin Y; Stadler C; Greif PA; Arseni N; Opatz S; Quintanilla-Fend L; Holzmann K; Hiddemann W; Döhner K; Döhner H; Xu G; Armstrong SA; Bohlander SK; Buske C
    Leukemia; 2011 Nov; 25(11):1718-27. PubMed ID: 21681188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients.
    Bohlander SK; Muschinsky V; Schrader K; Siebert R; Schlegelberger B; Harder L; Schemmel V; Fonatsch C; Ludwig WD; Hiddemann W; Dreyling MH
    Leukemia; 2000 Jan; 14(1):93-9. PubMed ID: 10637482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
    Wang Q; Qiu H; Jiang H; Wu L; Dong S; Pan J; Wang W; Ping N; Xia J; Sun A; Wu D; Xue Y; Drexler HG; Macleod RA; Chen S
    Haematologica; 2011 Dec; 96(12):1808-14. PubMed ID: 21880637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
    Archangelo LF; Gläsner J; Krause A; Bohlander SK
    Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.
    Caudell D; Harper DP; Novak RL; Pierce RM; Slape C; Wolff L; Aplan PD
    Blood; 2010 Feb; 115(6):1194-203. PubMed ID: 20007546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
    Dutta S; Krause A; Vosberg S; Herold T; Ksienzyk B; Quintanilla-Martinez L; Tizazu B; Chopra M; Graf A; Krebs S; Blum H; Greif PA; Vetter A; Metzeler K; Rothenberg-Thurley M; Schneider MR; Dahlhoff M; Spiekermann K; Zimber-Strobl U; Wolf E; Bohlander SK
    Leukemia; 2016 May; 30(5):1166-76. PubMed ID: 26686248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
    Klein BJ; Deshpande A; Cox KL; Xuan F; Zandian M; Barbosa K; Khanal S; Tong Q; Zhang Y; Zhang P; Sinha A; Bohlander SK; Shi X; Wen H; Poirier MG; Deshpande AJ; Kutateladze TG
    Nat Commun; 2021 Jul; 12(1):4130. PubMed ID: 34226546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
    Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice.
    Lange AP; Almeida LY; Araújo Silva CL; Scheucher PS; Chahud F; Krause A; Bohlander SK; Rego EM
    Braz J Med Biol Res; 2019; 52(6):e8424. PubMed ID: 31141090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.